CTLA4 and neoplasm: The interaction of CTLA-4 and its ligands generates an inhibitory signal and decreases or represses the viability of T cells [21].Blocking the interaction of CTLA-4 and ligandspromotes CD28 to bind the two ligands, activates T cells, improves the body’s immune response, and kills tumor cells.